Benefits and Limitations

associated with Cancer-Scan program
A personal decision for the screening candidate

The decision to test with PanTum® Detect is a personal one for every individual.

The individual needs to be aware of the limitations and should weigh these against the benefits of annual screening with PanTum® Detect.

BENEFITS
  • PanTum® Detect is a simple blood test
  • PanTum® Detect has a high sensitivity of 97.5% (true positives) and specificity of 99% (true negatives) per IVD CE validation study
  • PanTum® Detect is suitable for annual multi-cancer screening when integrated with Cancer-Scan
  • Only those screened candidates are exposed to imaging who test positive with PanTum® Detect
  • Annual screening increases the chance of detecting a silently growing tumor in an early stage
LIMITATIONS
  • PanTum® Detect is not suitable for individuals with a compromised immune system which has an effect on circulating macrophage numbers
  • No screening test provides a result that is 100% accurate or reliable
    • Statistically 1 in 100 candidates screened will receive a false positive result (they don’t have the disease but test positive)
    • Statistically 2.5 in 100 candidates with disease will receive false negative result (they do have disease but test negative)
  • False results are a psychological strain for individuals that get screened with PanTum® Detect